Categories: News

Vaccine Cold Chain Logistics Market worth $4.59 billion by 2028 – Exclusive Report by InsightAce Analytic

JERSEY CITY, N.J., Feb. 21, 2022 /PRNewswire/ — InsightAce Analytic Pvt. Ltd. announces the release of a market research report on “Global Vaccine Cold Chain Logistics Market– By Services (Storage, Packaging, and Transportation), By Packaging Methods (Dry Ice, Liquid Nitrogen, Gel Packs), Industry Competition Analysis, COVID-19 Impact Analysis, Revenue (US$ Billions) and Forecast Till 2028.” 

According to the latest market research report the global vaccine cold chain logistics market size was valued at US$ 3.12 Billion in 2021, and it is expected to reach US$ 4.59 Billion in 2028, recording a promising CAGR of 5.2% from 2022 to 2028.

Request Sample Report: https://www.insightaceanalytic.com/request-sample/1127

Well-defined cold chain infrastructure and established vaccine supply networks are essential to maintain the potency of vaccines/drugs. In the healthcare industry, cold supply chain logistics is one of the important parts of temperature-controlled shipping and storage of pharmaceutical products such as vaccines, and it can maintain the quality and safety of vaccines. Recent technological advancements aid in the innovation and development of vaccine cold chain logistics services.

The growth of the Vaccine cold chain logistics market can be credited to various factors, such as the surging demand for mRNA based Vaccine, increasing need for efficacious cold chain logistics services to maintain the quality of products,  high demand for infectious diseases vaccines, growing awareness among people about health & wellness, advancements in the packaging and transportation technologies, rising healthcare expenditure, and increasing R&D investments to develop vaccine storage facilities. The COVID-19 outbreak has significantly increased the demand for vaccine storage services, and hence, the pharmaceutical companies invested their efforts in developing cold chain logistics. Therefore, the rising R&D initiatives will likely offer new growth opportunities for the vaccine cold chain logistics market in the next few years. However, the high operational costs and the lack of standardized protocols for maintaining cold chain transportation are expected to hinder the market expansion during the forecast years.

Get the Detailed TOC: https://www.insightaceanalytic.com/report/global-vaccine-cold-chain-logistics-market/1127

The prominent players in the Vaccine Cold Chain Logistics industry include:

Cryoport (U.S.), DHL Express (Germany), GAC (Dubai), Lynden International Logistics (Canada), PAREXEL (U.S.), United Parcel Service (UPS Healthcare U.S.), DB Schenker (Germany), Yusen Logistics (U.S.), DB Schenker, CEVA Logistics, Q1 Scientific, Marken Ltd., AmeriCold Logistics LLC, FedEx Corporation, Yamato Logistics, and Other Prominent Players.  

The increasing investments by players in vaccine development programs, expanding pharmaceutical sector, developing cold supply chain services, and the rising government efforts to establish COVID-19 vaccines will offer promising growth opportunities for the market players operating in the vaccine cold supply chain logistics market.

Key Industry Developments from Leading Players:

  • In Octo 2021, Marken, the clinical trial logistics operation with UPS Healthcare (U.S.), expanded its global network to support rising demand for its clinical drug supply chain services, specifically for cell & gene clinical trials.
  • In Jul 2021, PAREXEL (U.S.), a leading global biopharmaceutical services provider, merged with EQT IX fund and private business within Goldman Sachs Asset Management for US$8.5 billion based on the company’s strong growth trajectory.
  • In May 2021, United Parcel Service (U.S.) consolidated all its cold-chain logistics and delivery services into a dedicated global operation that falls under the Atlanta-based company’s UPS Healthcare umbrella.
  • In Feb 2021, Renergen, South African natural gas and helium producer, started producing helium-powered ultra-cold mobile freezers to store the Covid Vaccine.

Vaccine Cold Chain Logistics Market Regional Analysis: North America majorly contributed to the vaccine cold chain logistics market in 2021 owing to the surging government initiatives for logistics infrastructure and the growing demand for cold chain storages systems. Asia Pacific is expected to witness rapid growth over the forecast period (2022-2030) due to the increasing demand for vaccines, rising R&D investments for pharmaceutical industry developments, and well-developed healthcare infrastructures. Factors such as the technological advancements in the storage and packaging of pharma products, high demand for cold chain systems, and the growing innovations in the pharmaceutical sector have made China a top market for cold chain logistics.

Inquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1127

The Global Vaccine Cold Chain Logistics Market Segments

The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Services

  • Storage
  • Packaging
  • Transportation

The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Packaging Methods

  • Dry Ice
  • Liquid Nitrogen
  • Gel Packs

The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Mode of Transportation

  • Ground
  • Air
  • Ocean

The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Holding Temperature Range

  • Vaccines Requiring Refrigerated Temperature
  • Vaccines Requiring Frozen Temperature
  • Vaccines Requiring Cryogenic Temperature

The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Container

  • Active Containers
  • Passive Containers

The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Region

  • Europe
  • North America
  • Latin America
  • Asia Pacific
  • Middle East & Africa

North America Vaccine Cold Chain Logistics Market Estimates Revenue (US$ Million) by Country, 2019 to 2028

  • U.S.
  • Canada

Europe Vaccine Cold Chain Logistics Market Estimates Revenue (US$ Million) by Country, 2019 to 2028

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Vaccine Cold Chain Logistics Market Estimates Revenue (US$ Million) by Country, 2019 to 2028

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Vaccine Cold Chain Logistics Market Estimates Revenue (US$ Million) by Country, 2019 to 2028

  • Brazil
  • Mexico
  • Rest of Latin America

The Middle East & Africa Vaccine Cold Chain Logistics Market Estimates Revenue (US$ Million) by Country, 2019 to 2028

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

For Customized Information @ https://www.insightaceanalytic.com/customisation/1127

Other Related Reports Published by InsightAce Analytic:

Global Swab And Viral Transport Medium Market

Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact Us:

Priyanka Tilekar
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Email: info@insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

View original content:https://www.prnewswire.com/news-releases/vaccine-cold-chain-logistics-market-worth-4-59-billion-by-2028—exclusive-report-by-insightace-analytic-301486330.html

SOURCE InsightAce Analytic Pvt. Ltd.

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

3 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

4 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

4 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

5 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

7 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

7 hours ago